Dr. Jonathan Patrick Schlebach's lab at Purdue University focuses on understanding how certain proteins, specifically membrane proteins, get misfolded and how this can lead to diseases like cystic fibrosis. They use cutting-edge techniques to explore how the production, quality control, and mutations of these proteins affect cellular health. This research aims to develop better therapies for patients with genetic variants of cystic fibrosis by optimizing treatment strategies.

Dr. Robert Graham Cooks leads a research lab at Purdue University focused on developing advanced methods for drug discovery using mass spectrometry. His team specializes in high-throughput screening, a powerful technique that allows for rapid analysis and synthesis of potential therapeutic compounds. The lab's innovative work aims to discover new treatments, particularly for advanced-stage prostate cancer, by efficiently combining chemical synthesis and biological testing.

Dr. Arun Ghosh's lab at Purdue University focuses on developing new treatments for HIV/AIDS, particularly through the design and synthesis of innovative protease inhibitors. These inhibitors aim to overcome challenges posed by drug-resistant strains of the virus and improve treatment for patients experiencing complications such as neurocognitive disorders. The lab employs advanced techniques in chemistry and biology to create more effective antiviral agents that are essential for long-term HIV management.

Dr. Elizabeth Ivy Parkinson's lab at Purdue University focuses on discovering novel medicine from soil bacteria called Streptomyces. They analyze the genetic blueprints of these bacteria to find hidden pathways that could lead to new bioactive compounds, specifically cyclic peptides. Another goal is to develop unique enzymes that can be used to create these promising compounds more efficiently, enhancing the laboratory's capability to synthesize and test potential new drugs.